Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Bode

Showing results (191-200 of 600) with videos related to

Pageof 60
Sort By:
Frontiers in Cardiovascular Medicine|July 6, 2019
Cytokine Adsorption in Critically Ill Patients Requiring ECMO SupportAchim Lother, Christoph Benk, Dawid L Staudacher, et al.
International Journal of Cardiology|February 8, 2011
Evidence for non-ischemic scarring in patients with ventricular ectopyMichael Jeserich, Matthias G Friedrich, Manfred Olschewski, et al.
Scientifica|March 27, 2015
Unprotected left main percutaneous coronary intervention in acute coronary syndromes with extracorporeal life support backupDawid L Staudacher, Oliver Langner, Paul Biever, et al.
Thrombosis and Haemostasis|November 1, 2013
Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registryChristoph B Olivier, Philipp Diehl, Katharina Schnabel, et al.
Critical Care (London, England)|June 5, 2016
Inflammasome and toll-like receptor signaling in human monocytes after successful cardiopulmonary resuscitationAlexander Asmussen, Katrin Fink, Hans-Jörg Busch, et al.
Journal of Thrombosis and Thrombolysis|February 4, 2016
Platelet reactivity after administration of third generation P2Y12-antagonists does not depend on body weight in contrast to clopidogrelChristoph B Olivier, Katharina Schnabel, Susanne Weber, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 14, 2019
Influence of glycoprotein IIb/IIIa inhibitors on bleeding events after successful resuscitation and percutaneous coronary interventionPaul Marc Biever, Dawid Leander Staudacher, Jonas Degott, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 19, 2021
Do Inpatients Receive Risk-Based Prophylactic Treatment for Thrombotic Events?Armin Nemani, Constantin von Zur Mühlen, Friederike Steffen, et al.
Herz|December 7, 2007
Sirolimus-eluting versus bare-metal stents for the reduction of coronary restenosis: 18-month angiographic results from the GERSHWIN StudyBernd Brüggenjürgen, Doreen McBride, Christoph Bode, et al.
Clinical Cardiology|March 31, 2012
Evidence of myocardial edema in patients with nonischemic dilated cardiomyopathyMichael Jeserich, Daniela Föll, Manfred Olschewski, et al.
Pageof 60

Showing results (191-200 of 600) with videos related to

Sort By:
Pageof 60
Frontiers in Cardiovascular Medicine|July 6, 2019
Cytokine Adsorption in Critically Ill Patients Requiring ECMO SupportAchim Lother, Christoph Benk, Dawid L Staudacher, et al.
International Journal of Cardiology|February 8, 2011
Evidence for non-ischemic scarring in patients with ventricular ectopyMichael Jeserich, Matthias G Friedrich, Manfred Olschewski, et al.
Scientifica|March 27, 2015
Unprotected left main percutaneous coronary intervention in acute coronary syndromes with extracorporeal life support backupDawid L Staudacher, Oliver Langner, Paul Biever, et al.
Thrombosis and Haemostasis|November 1, 2013
Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registryChristoph B Olivier, Philipp Diehl, Katharina Schnabel, et al.
Critical Care (London, England)|June 5, 2016
Inflammasome and toll-like receptor signaling in human monocytes after successful cardiopulmonary resuscitationAlexander Asmussen, Katrin Fink, Hans-Jörg Busch, et al.
Journal of Thrombosis and Thrombolysis|February 4, 2016
Platelet reactivity after administration of third generation P2Y12-antagonists does not depend on body weight in contrast to clopidogrelChristoph B Olivier, Katharina Schnabel, Susanne Weber, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 14, 2019
Influence of glycoprotein IIb/IIIa inhibitors on bleeding events after successful resuscitation and percutaneous coronary interventionPaul Marc Biever, Dawid Leander Staudacher, Jonas Degott, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 19, 2021
Do Inpatients Receive Risk-Based Prophylactic Treatment for Thrombotic Events?Armin Nemani, Constantin von Zur Mühlen, Friederike Steffen, et al.
Herz|December 7, 2007
Sirolimus-eluting versus bare-metal stents for the reduction of coronary restenosis: 18-month angiographic results from the GERSHWIN StudyBernd Brüggenjürgen, Doreen McBride, Christoph Bode, et al.
Clinical Cardiology|March 31, 2012
Evidence of myocardial edema in patients with nonischemic dilated cardiomyopathyMichael Jeserich, Daniela Föll, Manfred Olschewski, et al.
Pageof 60